Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,500
Closed -$585K 453
2023
Q1
$585K Buy
+5,500
New +$594K ﹤0.01% 251
2022
Q4
Sell
-55,700
Closed -$4.8M 149
2022
Q3
$4.8M Buy
55,700
+49,700
+828% +$4.44M 0.03% 203
2022
Q2
$547K Sell
6,000
-131,300
-96% -$11.6M ﹤0.01% 444
2022
Q1
$11.3M Buy
137,300
+102,800
+298% +$8.1M 0.05% 108
2021
Q4
$2.64M Buy
+34,500
New +$2.75M 0.01% 382
2021
Q3
Sell
-60,200
Closed -$4.87M 835
2021
Q2
$4.87M Sell
60,200
-65,979
-52% -$4.91M 0.02% 299
2021
Q1
$9.28M Buy
+126,179
New +$9.31M 0.04% 122
2019
Q4
Sell
-85,726
Closed -$6.89M 717
2019
Q3
$6.89M Buy
85,726
+17,501
+26% +$1.4M 0.09% 186
2019
Q2
$5.46M Sell
68,225
-26,095
-28% -$2M 0.05% 214
2019
Q1
$7.49M Buy
+94,320
New +$7.05M 0.08% 226

Other funds holding MRK

HBK Investments's MRK Position: Q3 2023 in Review

HBK Investments sold out of Merck (MRK) in Q3 2023, closing a stake of 27,712 shares — an estimated $3.2M sold.

HBK Investments first reported a position in MRK in Q2 2014 and held it in 17 quarters. The position peaked at $40.3M in Q2 2017. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • HBK Investments reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 27,712 Merck shares in Q3 2023, an estimated $3.2M.
  • HBK Investments first reported a position in Merck in Q2 2014 and held it in 17 quarters.
  • HBK Investments's Merck position peaked at $40.3M in Q2 2017.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.